This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

Swimming short fibrous nasal drops achieve intraventricular administration

Swimming short fibrous nasal drops achieving intraventricular administration
Inspired by swimming fish and the microstructure of the nasal cavity, short-swimming fibrous nasal drops with the ability to transport drugs along the nasal mucosa were innovatively constructed by guiding electrospun fibers into the swimming short fibrous nasal drops via electrospinning, homogenization, and subsequent multifunctional modifications to achieve precise intraventricular administration by targeting the nasal mucosa and controlling drug release along with the swing of the nasal cilia. Credit: Science China Press

Adequate drug delivery across the blood-brain barrier is a critical factor in treating central nervous system (CNS) disorders. Inspired by swimming fish and the microstructure of the nasal cavity, Prof. Cui is the first to develop swimming short fibrous nasal drops that can directly target the nasal mucosa and swim in the nasal cavity, which can effectively deliver drugs to the brain. The paper is published in the journal Science Bulletin.

Swimming short fibrous nasal drops with charged controlled drug release were fabricated by electrospinning, homogenization, the π-π conjugation between indole group of fibers, the benzene ring of leucine-rich repeat kinase 2 (LRRK2) inhibitor along with charge-dipole interaction between positively charged poly-lysine (PLL) and negatively charged surface of fibers, which enabled these fibers to stick to the nasal mucosa, prolonged the on the mucosa, and prevented rapid mucociliary clearance.

In vitro, swimming short fibrous nasal drops were biocompatible and inhibited microglia activation by releasing LRRK2 inhibitor. In vivo, luciferase-labeled swimming short fibrous nasal drops delivered LRRK2 inhibitor to the brain through the , alleviating cognitive dysfunction caused by sepsis-associated encephalopathy by inhibiting microglial inflammation and improving synaptic plasticity.

"These newly developed swimming short fibrous nasal drops are a promising strategy for the treatment of CNS diseases," Prof. Wenguo Cui says.

Prof. Cui (Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine) and Dr. Buwei Yu led this study.

More information: Juan Wang et al, Swimming short fibrous nasal drops achieving intraventricular administration, Science Bulletin (2024). DOI: 10.1016/j.scib.2024.03.013

Citation: Swimming short fibrous nasal drops achieve intraventricular administration (2024, April 23) retrieved 17 June 2024 from https://medicalxpress.com/news/2024-04-short-fibrous-nasal-intraventricular-administration.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Relieve your stress, relieve your allergies

0 shares

Feedback to editors